Raymond James Trust N.A. Catalyst Biosciences, Inc. Transaction History

Raymond James Trust N.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 20, 2021	SELL	$4.1 - $5.33 $45,099 - $58,630	-11,000 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$4.93 - $7.15 $54,230 - $78,650	11,000 New	11,000 $55,000
Q4 2020 Jan 13, 2021	SELL	$4.55 - $7.29 $63,700 - $102,060	-14,000 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$4.22 - $6.04 $59,080 - $84,560	14,000 New	14,000 $60,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

Stay updated on Raymond James Trust N.A. with notifications on news.